drugset / Trial / NCT00045747
UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Open-labelTreatment
Summary
RATIONALE: UCN-01 may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining UCN-01 with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining UCN-01 with fluorouracil in treating patients who have metastatic pancreatic cancer that has not responded to treatment with gemcitabine.
Timeline
- Start
- 2002-07
- Primary completion
- —
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UCN-01 | Small molecule | — | Intravenous |
| Subject | fluorouracil | Small molecule | — | Intravenous |